Furthermore,research involving animal models of hypertension, heart failure, and kidneydisease has highlighted its dose-dependent anti-fibrotic and organ-protectiveeffects, which are consistent with the mode of action of sGC stimulators [7]. This evidence concerns the gene SGCB and heart failure.